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NMR spectroscopyThe frog skin peptide temporin L (TL, 13-residues long) has a wide and potent spectrum of antimicrobial ac-
tivity, but it is also toxic on mammalian cells at its microbicidal concentrations. Previous studies have indicat-
ed that its analogue [Pro3]TL has a slightly reduced hemolytic activity and a stable helical conformation along
residues 6–13. Here, to expand our knowledge on the relationship between the extent/position of α-helix in
TL and its biological activities, we systematically replaced single amino acids within the α-helical domain of
[Pro3]TL with the corresponding D isomers, known as helix breakers. Structure–activity relationship studies
of these analogues, by means of CD and NMR spectroscopy analyses as well as antimicrobial and hemolytic
assays were performed. Besides increasing our understanding on the structural elements that are responsible
for cell selectivity of TL, this study revealed that a single L to D amino acid substitution can preserve strong
anti-Candida activity of [Pro3]TL, without giving a toxic effect towards human cells.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
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[1,2]. Antimicrobial peptides (AMPs) existing in virtually all species of
life have been shown to exert direct killing activity on a large number
of invading microorganisms. They represent the most ancient and
fast-acting elements of the host's innate defence system against micro-
bial pathogens [3,4]. At present, these AMPs are considered as promis-
ing candidates for the generation of a new class of anti-infective
agents [5–8]. They have been thoroughly investigated particularly in
those animals (e.g. insects) lacking an adaptive immune system [9].
However, a large part of the current knowledge on the peptide-
mediated innate immunity comes from studies performed with mam-
malian AMPs and with AMPs from amphibian skin secretions that are
known to be a rich storehouse of various bioactive peptides [10,11]. Al-
though the exact mode of action of AMPs has not been established yet,
all of them interactwithmicrobialmembranes. They accumulatewithin
the membranes and increase their permeability causing the loss of bar-
rier function and death of the microbe [12,13]. Note that recent high
resolution structural studies have provided important mechanistic in-
sights into the conformation of AMPs required for their translocation
across the lipopolysaccharide (LPS or endotoxin) outer membrane of
Gram-negative bacteria [14,15], as well as for their ability to permeate
phospholipid bilayers mimicking various membranes, via the barrel-
stave or carpet-like mechanism (as e.g. in the case of pardaxin [16,17],
LL-37 [18], and MSI-594, a synthetic hybrid of MSI-78 and melittin
[19,20]). Alternatively, peptides can enter the cell and inhibit vital
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multiple targeting and physical disruption of fundamental physiological
cell structures (i.e. the cytoplasmic membrane) makes bacteria and
fungi less likely to become resistant to AMPs, compared to conventional
antimicrobials that usually act via a receptor-mediated mechanism
[26,27].
The skin of several frog species, such as those belonging to the
Rana genus, has proved to be an inexhaustible source of AMPs with
a wide spectrum of activity [28,29]. For example, the amphibian
temporins represent one of the largest families (more than 100 mem-
bers) and are among the smallest-sized AMPs (10–14 amino acids)
found in nature to date. They are mildly cationic peptides, due to
the presence of only 1 or 2 basic residues in their sequence; they
are amidated at the C-terminus and adopt an amphipathic α-helical
preferential conformation in a hydrophobic environment [30]. Gener-
ally speaking, temporins are known to be active particularly against
Gram-positive bacteria, with minimal inhibitory concentrations rang-
ing from 2.5 μM to 20 μM. The only exception is given by the isoform
temporin TL (TL, H-Phe1-Val2-Gln3-Trp4-Phe5-Ser6-Lys7-Phe8-Leu9-
Gly10-Arg11-Ile12-Leu13-NH2), as it is strongly active also against
Gram-negative bacteria and yeast strains [31]. The bacterial killing ki-
netics of temporins overlaps that of membrane perturbation [32]. As
found for other AMPs, some temporins have shown immunomodula-
tory properties (e.g. chemotactic to human phagocytes [33]) and can
neutralize the toxic effect of LPS [34]. In this context, important NMR
studies of different native or de-novo designed host-defence peptides
have recently been carried out to know the speciﬁc conformation of
AMPs in their LPS-bound state [14,20,35].
Furthermore, temporins synergize when combined with other
temporin-isoforms (i.e. the couples TA+TL and TB+TL) in both the an-
timicrobial and anti-endotoxin activities [36,37]. Most of them are prac-
tically non-hemolytic, but the highly potent temporin L kills human
erythrocytes at microbicidal concentrations [31] and was revealed to
be toxic in vivo, when tested on Caenorhabditis elegans worms [38].
Therefore, to be developed as a future broad spectrum antibiotic, it is
necessary to increase its therapeutic index which is deﬁned as the
ratio between the concentration of its hemolytic activity and antimicro-
bial activity [39]. Recent studies on the structure/activity relationships of
both native TL and its synthetic analogues have clearly indicated the ex-
istence of a direct correlation between the hemolytic activity of the pep-
tide and its α-helical content [40]. In contrast, no such connection was
found with the antimicrobial activity. Indeed, disrupting the peptide's
α-helix at its N-terminus by replacing Gln3 with a proline ([Pro3]TL)
did not signiﬁcantly affect the antibacterial activity, while the hemolytic
activity was reduced by more than half, up to 12 μM, a concentration
causing about 90% hemolysis for the native TL [41]. Interestingly, the
effects of proline substitution on the biological activity of other am-
phibian skin AMPs, such as maculatin peptide from the Australian
tree frog species Litoria genimaculata, have been previously evaluat-
ed [42]. Similar to our ﬁndings with TL analogues, removal of proline
in maculatin 1.1 increased the peptide's interaction with neutral
phospholipid bilayers, together with enhanced hemolytic activity.
However, in contrast with what has been found with TL analogues,
this was accompanied by a strong reduction in the antibiotic activity
and lytic effect of maculatin on anionic membranes [42,43].
Nevertheless, the disruption of the α-helix of TL at its N and
C-terminal ends, by replacing Gln3 and Gly10 with Pro ([Pro3, Pro10]
TL), induced a drastic decrease in both the hemolytic and anti-
bacterial activities [40]. Previous NMR studies with [Pro3]TL in
sodium dodecylsulphate (SDS) and dodecylphosphocholine (DPC)
micelles, mimicking the anionic and zwitterionic character of bacteri-
al and erythrocyte membrane, respectively [41], revealed a stable he-
lical conformation along residues 6–13 [44]. Here, to get a deeper
insight into the relationship between the extent/position of the
α-helix along the sequence of TL and the biological activity of this
peptide, six derivatives of [Pro3]TL were synthesized and analyzedby means of antimicrobial and hemolytic assays combined with CD
and NMR spectroscopy. More speciﬁcally, such derivatives were
obtained by a systematic replacement of single residues within the
α-helix domain (Lys7 to Leu13) of [Pro3]TL with D enantiomers,
known as helical breakers. The results provide a better understanding
on the structural elements that are responsible for the cell selectivity
of TL. Most importantly, we have identiﬁed an analogue endowed
with high anti-Candida activity, a slightly reduced antibacterial
potency than the native TL, but practically devoid of any lytic effect
on mammalian cells. This novel TL derivative represents a fascinating
template for the development of novel temporin-based anti-infective
drugs with increased therapeutic index.
2. Materials and methods
2.1. Materials
Nα-Fmoc-protected amino acids, 2-(1H-benzotriazole-1-yl)-1,
1,3,3-tetramethyluronium hexaﬂuoro-phosphate (HBTU), N-hydroxy-
benzotriazole (HOBt) and Rink amide resin were purchased from
GL Biochem Ltd (Shanghai, China). Peptide synthesis solvents, re-
agents, as well as CH3CN for HPLC were reagent grade and were
acquired from commercial sources and used without further puriﬁ-
cation unless otherwise noted. See Supplementary material for
more details on peptide synthesis and analytical data (Supplemen-
tary Table S1).
The following lipids: 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine (POPE); 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoglycerol (POPG); cardiolipin (CL); 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC) and cholesterol (Cho) were
purchased from Avanti Polar Lipids (Alabaster, AL, USA). SDS-d25
and DPC-d38 were obtained from Cambridge Isotope Laboratories,
Inc. (Andover, MA); calcein, from Sigma (St Louis, MO, USA). All
other chemicals used were of reagent grade.
2.2. Microorganisms
The strains used for the antimicrobial assays were the follow-
ing: the Gram-negative bacteria Acinetobacter baumannii ATCC
19606, Acinetobacter junii RT-4, Escherichia coli ATCC 25922, E.
coli D21, Pseudomonas aeruginosa ATCC 15692, P. aeruginosa
ATCC 27853, Pseudomonas syringae pv tabaci 1918NCPPB, and
Yersinia pseudotuberculosis YPIII; the Gram-positive bacteria Bacillus
megaterium Bm11, Staphylococcus aureus ATCC 25923, S. aureus Cowan
I, Staphylococcus capitis 1, Staphylococcus epidermidis ATCC 12228, and
Streptococcus pyogenes ATCC 21547 and the yeasts Candida albicans
ATCC 10231, C. albicans clinical isolates (strains n. 1, 2, 3 and 4),
Saccharomyces cerevisiae, and Saccharomyces pombe.
2.3. Antimicrobial assay
Susceptibility testing was performed by adapting the microbroth
dilution method outlined by the Clinical and Laboratory Standards
Institute, using sterile 96-well plates (Falcon NJ, USA). The growth
of the bacterial and yeast cells was aseptically measured by absor-
bance at 590 nm with a spectrophotometer (UV-1700 Pharma Spec
Shimadzu, Tokyo, Japan). Afterwards, aliquots (50 μL) of bacteria in
mid-log phase at a concentration of 2×106 colony-forming units
(CFU)/mL in culture medium (Mueller-Hinton, MH) were added to
50 μL of MH broth containing the peptide in serial 2-fold dilutions
ranging from 0.75 to 48 μM. The same procedure was followed with
yeasts inWingemedium [45] (a ﬁnal cell concentration of approximately
3.5×104 CFU/mL and 3×105 CFU/mL for Candida and Saccharomyces
strains, respectively). Inhibition of microbial growth was determined by
measuring the absorbance at 590 nm, after an incubation of 18 h at
37 °C (30 °C for yeasts), with a microplate reader (Inﬁnite M200; Tecan,
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inhibitory concentration (MIC), the concentration of peptide at which
100% inhibition of microbial growth is observed after 18 h of incubation.2.4. Hemolytic assay
The hemolytic activity was measured on human red blood cells as
reported previously [40]. Freshly collected human blood with EDTA
was centrifuged for 10 min at 1000×g and the erythrocytes obtained
were washed three times with 0.9% (w/v) NaCl, centrifuged as above,
and resuspended in 0.9% NaCl to approximately 1.5×108 cells/mL.
Then, 95 μL aliquots of the erythrocyte suspension were incubated
with 5 μL of serial two-fold dilutions of the peptide for 40 min at
37 °C with gentle mixing. The samples were then centrifuged and the
absorbance of the supernatant was measured at 415 nm. Complete
lysis was measured by suspending erythrocytes in distilled water [46].2.5. Cytotoxic activity
The cytotoxic effect of the peptides was determined by the inhibi-
tion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) reduction to insoluble formazan, by mitochondrial reductases,
on the immortalized human keratinocyte (HaCaT) cells. Cells were
cultured in Dulbecco's modiﬁed Eagle's medium (DMEM; Sigma)
supplementedwith 10% heat-inactivated fetal bovine serum, glutamine
(4 mM) and antibiotics (penicillin and streptomycin) and then plated
in triplicate wells at 1×104 cells/well (96-well plates were used).
After 2 h at 37 °C in a 5% CO2 atmosphere, the medium was replaced
with 100 μL fresh DMEM supplemented with the peptide at different
concentrations. The plate was then incubated for 90 min at 37 °C in a
5% CO2 atmosphere. Afterwards, the medium was removed and re-
placed with fresh DMEM containing 0.5 mg/mL MTT. After 4-h incuba-
tion, the formazan crystals were dissolved by adding 100 μL of acidiﬁed
isopropanol and viability was determined by absorbance measure-
ments at 595 nm. Cell viability was calculated with respect to control
cells (cells not treated with peptide).2.6. Calcein-loaded large unilamellar vesicles (LUV) and leakage assay
Lipid ﬁlms of POPE/POPG (7:3, w/w), POPG/CL (6:4, w/w), and
POPC/Cho (9:1, w/w) were prepared by dissolving dry lipids (2 mg of
each lipid mixture) in chloroform/methanol (2:1, v/v) and evaporating
the solvents under a nitrogen stream. The lipid ﬁlm was then hydrated
with 10 mM Tris and 150 mMNaCl (pH 7.4) containing 60 mM calcein
solution. The liposome suspension was extruded 10 times through a
polycarbonate ﬁlter (pore size, 0.1 μm), and free calcein was removed
by gel ﬁltration, using a Sephadex G-25 column (1.5×10 cm; Pharmacia
Biotech AB Uppsala, Sweden) at room temperature. Calcein in the vesi-
cles is highly concentrated, and the ﬂuorescence is self-quenched.
Calcein release induced by the peptide was monitored at 37 °C by the
ﬂuorescence increase (λexcitation=485 nm; λemission=535 nm).
Complete dye release was obtained using 0.1% Triton X-100, which
causes total destruction of lipid vesicles [47].2.7. Circular dichroism (CD)
All CD spectra were recorded using a JASCO J710 spectropolarimeter
at 25 °C with a cell of 1 mm path length. The CD spectra were acquired
in the range of 260–190 nm, 1 nm bandwidth, 4 accumulations, and
100 nm/min scanning speed. The CD spectra of TL and TL derivates, at
a concentration of 100 μM, were performed in phosphate buffer
(pH=7.4), SDS (20 mM), DPC (20 mM), or DPC/SDS 18/2 mMmicellar
solutions.2.8. Nuclear magnetic resonance (NMR) spectroscopy
The samples for NMR spectroscopy were prepared by dissolving the
appropriate amount of [Pro3, DLeu9]TL in 0.55 mL of 1H2O, 0.05 mL of
2H2O to obtain a concentration of 1–2 mM peptide and 200 mM
SDS-d25 or DPC-d38. The NMR experiments were performed at pH 5.0.
NH exchange studies were performed by dissolving peptide in
0.60 mL of 2H2O and 200 mM SDS-d25 or DPC-d38. NMR spectra were
recorded on a Varian Unity INOVA 700 MHz spectrometer equipped
with a z-gradient 5 mm triple-resonance probe head. All the spectra
were recorded at a temperature of 25 °C. The spectra were calibrated
relative to 3-(trimethylsilanyl)propionic acid (0.00 ppm) as internal
standard. One-dimensional (1D) NMR spectra were recorded in the
Fourier mode with quadrature detection. 2D DQF-COSY [48,49],
TOCSY [50], and NOESY[51] spectra were recorded in the phase-
sensitive mode using the method from States [52]. Data block sizes
were 2048 addresses in t2 and 512 equidistant t1 values. A mixing
time of 70 ms was used for the TOCSY experiments. NOESY experi-
ments were run with mixing times in the range of 150–300 ms. The
water signal was suppressed by gradient echo [53]. The 2DNMR spectra
were processed using the NMRPipe package [54]. Before Fourier trans-
formation, the time domain data matrices were multiplied by shifted
sin2 functions in both dimensions, and the free induction decay size
was doubled in F1 and F2 by zero ﬁlling. The qualitative and quantita-
tive analyses of DQF-COSY, TOCSY and NOESY spectra were obtained
using the interactive program package XEASY [55]. 3JHN-Hα couplings
were difﬁcult to measure probably because of a combination of small
coupling constants and broad lines. The temperature coefﬁcients of
the amide proton chemical shifts were calculated from 1D 1H NMR
and 2D TOCSY experiments performed at different temperatures in
the range of 298–320 K by means of linear regression.
2.9. Structural determinations
The NOE-based distance restraints were obtained from NOESY
spectra collected with a mixing time of 200 ms. Peak volumes were
translated into upper distance bounds with the CALIBA routine from
the DYANA software package [56]. The requisite pseudoatom correc-
tions were applied for non-stereospeciﬁcally assigned protons at
prochiral centers and for the methyl group. After discarding redun-
dant and duplicated constraints, the ﬁnal list of constraints was
used to generate an ensemble of 200 structures by the standard
DYANA protocol of simulated annealing in torsion angle space. No di-
hedral angle restraints and no hydrogen bond restraints were applied.
An error tolerant target function (tf type 3) was used to account for
the peptide intrinsic ﬂexibility. Then, 20/200 structures were chosen,
whose interproton distances best ﬁtted NOE derived distances, and
reﬁned through successive steps of restrained and unrestrained ener-
gy minimization calculations using the Discover algorithm (Accelrys,
San Diego, CA) and the consistent valence force ﬁeld [57]. No residue
was found in the disallowed region of the Ramachandran plot. The
ﬁnal structures were analyzed using the InsightII program (Accelrys,
San Diego, CA). Graphical representations were carried out with the
InsightII program. The root-mean-squared-deviation analysis be-
tween energy-minimized structures was carried out with the pro-
gram MOLMOL [58]. The PROMOTIF program was used to extract
details on the location and types of structural secondary motifs [59].
3. Results
3.1. Biological activity
The antibacterial, anti-yeast and hemolytic activities of the
synthesized [Pro3]TL analogues (Table 1) were compared with those
of TL and [Pro3]TL. The data highlighted the following: (i) Replace-
ment of Lys7 with its DLys enantiomer considerably reduced the
Table 1
Sequences of TL analogues.
Compound Sequencesa
TLb H-Phe1-Val2-Gln3-Trp4-Phe5-Ser6-Lys7-Phe8-Leu9-Gly10-Arg11-Ile12-Leu13-NH2
[Pro3]TLb H-Phe1-Val2-Pro3-Trp4-Phe5-Ser6-Lys7-Phe8-Leu9-Gly10-Arg11-Ile12-Leu13-NH2
[Pro3, DLys7]TL H-Phe1-Val2-Pro3-Trp4-Phe5-Ser6-DLys7-Phe8-Leu9-Gly10-Arg11-Ile12-Leu13-NH2
[Pro3, DPhe8]TL H-Phe1-Val2-Pro3-Trp4-Phe5-Ser6-Lys7-DPhe8-Leu9-Gly10-Arg11-Ile12-Leu13-NH2
[Pro3, DLeu9]TL H-Phe1-Val2-Pro3-Trp4-Phe5-Ser6-Lys7-Phe8-DLeu9-Gly10-Arg11-Ile12-Leu13-NH2
[Pro3, DArg11]TL H-Phe1-Val2-Pro3-Trp4-Phe5-Ser6-Lys7-Phe8-Leu9-Gly10-DArg11-Ile12-Leu13-NH2
[Pro3, DIle12]TL H-Phe1-Val2-Pro3-Trp4-Phe5-Ser6-Lys7-Phe8-Leu9-Gly10-Arg11-DIle12-Leu13-NH2
[Pro3, DLeu13]TL H-Phe1-Val2-Pro3-Trp4-Phe5-Ser6-Lys7-Phe8-Leu9-Gly10-Arg11-Ile12-DLeu13-NH2
a Residue variations compared to TL are highlighted in bold.
b Already described in references [40,41].
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negative bacteria. Indeed, its MIC value was 2 to 8-fold higher than
that of TL and [Pro3]TL (Table 2). More speciﬁcally, [Pro3, DLys7]TL al-
most lost activity against the Gram-negative P. aeruginosa and E. coli
strains. Furthermore, a 2-fold higher MIC was found against C. albicans
and S. pombe. However, the lytic effect on human red blood cells was
dramatically reduced compared to [Pro3]TL (8% hemolysis versus 92%
at 24 μM) (Table 3). (ii) Replacing the ﬂanking Phe8 with DPhe ([Pro3,
DPhe8]TL), reduced 2–4 fold the antibacterial/anti-yeast activity, where-
as the hemolytic activity became lower than that observed with [Pro3]
TL but higher compared to [Pro3, DLys7]TL (Table 3). (iii) Interestingly,
when Leu9 was replaced with DLeu ([Pro3, DLeu9]TL), the antibacterial
activity was equal or two-fold lower than that of TL (a 4-fold reduction
against two strains out of 14), with an identical efﬁcacy against Candida
and Saccharomyces strains. Furthermore, the lytic activity on erythro-
cytes was almost completely abolished, causing only 9% hemolysis at a
concentration of 48 μM (Table 3). (iv) Replacing the Arg residue in po-
sition 11 with its D enantiomer also resulted in a lower activity (2 to
4-fold higher MIC for the analogue compared with the wild type TL)
against both Gram-positive and Gram-negative bacteria (8-fold higher
MIC only in the case of S. capitis). However, the anti-yeast activity was
weakly affected (Table 2). The percentage of hemolysis caused by this
peptide was much lower than that of TL (16% lysis at 24 μM and 22%
lysis at 48 μM); nevertheless, it was higher than that shown by the afore-
mentioned [Pro3, DLys7]TL and [Pro3, DLeu9]TL analogues (Table 3). (v)
When the chirality of the penultimate Ile residue changed to the D
conﬁguration, a 4-fold lower activity than TL was displayed againstTable 2
Antimicrobial activity of the synthesized compounds.
MICa (μ
Strains TL [Pro3]
TL
[Pro3, DLys7]
TL
[P
TL
Gram-negative bacteria
Acinetobacter baumannii ATCC 19606 6 6 24
Acinetobacter junii RT-4 3 6 6
Escherichia coli ATCC 25922 12 24 >48
Escherichia coli D21 12 12 48
Pseudomonas syringae pv tabaci 6 6 >48
Pseudomonas aeruginosa ATCC 15692 24 24 >48 >
Pseudomonas aeruginosa ATCC 27853 >48 >48 >48 >
Yersinia pseudotuberculosis YPIII 3 3 12
Gram-positive bacteria
Bacillus megaterium Bm11 1.5 1.5 3
Staphylococcus aureus ATCC 25923 3 3 24
Staphylococcus aureus Cowan I 3 1.5 12
Staphylococcus capitis 1 1.5 1.5 12
Staphylococcus epidermidis ATCC 12228 3 1.5 6
Streptococcus pyogenes ATCC 21547 6 6 12
Yeasts
Candida albicans ATCC 10231 3 3 6
Saccharomyces pombe 6 3 12
Saccharomyces cerevisiae 6 6 6
a The reported MIC values are those obtained from at least three readings out of four indGram-positive strains. The activity on Gram-negative bacteria also de-
creased, but to a lesser extent. The toxic effect on human erythrocytes
was comparable to that of [Pro3, DArg11]TL. (vi) Finally, when the last res-
idue Leu13 was replaced by its D enantiomer, the antibacterial/anti-yeast/
hemolytic activitieswere generally found to overlap those of [Pro3, DIle12]
TL.
3.2. Peptides' activity on C. albicans clinical isolates
To further expand our knowledge on the anti-Candida activity of the
best analogue ([Pro3, DLeu9]TL), several clinical isolates of C. albicans
were analyzed for their susceptibility to this analogue and to the native
TL. An antimycotic resistant strain was also included for comparison. As
indicated in Table 4, the same MICs were obtained for the two peptides
on all the microorganisms tested.
3.3. Cytotoxicity towards human keratinocytes
The ﬁnding of a TL derivative ([Pro3, DLeu9]TL) with a highly
reduced hemolytic activity and with a similar or identical antimicrobial
potency on bacteria or Candida cells, prompted us to determine its tox-
icity against another important type of eukaryotic cells, i.e. themamma-
lian keratinocytes, which are present in several tissues colonized by
Candida cells such as the skin, the oral mucosa as well as the corneal,
conjunctival and genital epithelia. Remarkably, as reported in Table 5,
viability of human keratinocytes after treatmentwith thenative peptide
ranged from 39% to 23%, at a concentration range from 6 to 48 μM; inM)
ro3, DPhe8] [Pro3, DLeu9]
TL
[Pro3, DArg11]
TL
[Pro3, DIle12]
TL
[Pro3, DLeu13]
TL
12 12 12 24 12
12 3 6 3 3
12 12 24 24 24
24 12 24 12 12
12 24 12 12 12
48 >48 >48 48 48
48 >48 >48 48 >48
6 6 12 12 6
3 1.5 3 3 3
6 6 12 12 12
6 6 6 12 6
6 6 12 12 12
6 6 6 12 12
6 6 12 12 12
6 3 6 6 6
6 6 6 6 6
12 6 6 6 6
ependent measurements.
Table 3
Hemolytic activity of TL-analogues on human erythrocytes.
Hemolysis (%)a
[Peptide] (μM) TLb [Pro3]
TLb
[Pro3, DLys7]
TL
[Pro3, DPhe8]
TL
[Pro3, DLeu9]
TL
[Pro3, DArg11]
TL
[Pro3, DIle12]
TL
[Pro3, DLeu13]
TL
48 100 100 18 94 9 22 17 15
24 94 92 8 19 8 16 14 17
12 92 42 5 19 7 8 10 17
6 48 10 7 17 3 6 5 8
3 13 6 4 5 2 4 4 6
1.5 3 4.5 2 4 2 2 2 3
a Values are the mean of three independent experiments with SD not exceeding 1.5%.
b Values already reported in references [31,32].
Table 5
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the highest peptide concentration used (48 μM).
3.4. Structural studies
3.4.1. CD analysis
To explore the conformational changes of TL analogues, we
performed CD spectroscopy studies in phosphate buffer (pH 7.4),
DPC, SDS, and DPC/SDS micelle solutions. These micelles were used
as rough mimetics of mammalian, bacterial and yeast membranes,
respectively. CD spectra in phosphate buffer revealed the presence
of disordered conformers for all compounds with a minimum close
to 198 nm (data not shown). In contrast, in DPC (Fig. 1a), SDS
(Fig. 1b), and DPC/SDS (Fig. 1c) micelle solutions, the shape of the
CD spectra displaying two minima around 209 and 222 nm supports
the contribution of an α-helix. CD spectra of [Pro3, DLeu9]TL in the
three environments are shown in Fig. 1d. Helical content was predict-
ed from CD spectra using the SOMCD method [60] (Table 6). Since CD
spectra for short peptides are more affected by the termini than for
long proteins, the error bars for helical content would be of order
10%. The helical content of [Pro3]TL is included for comparison. All
the D analogues showed a reduction in the percentage of helicity com-
pared to [Pro3]TL, in agreement with the design strategy. Further-
more, helical content observed in both SDS and DPC/SDS was about
20% reduced compared to DPC. Indeed, as illustrated in Table 6, helical
content of all peptides ranged from 24% to 10% in DPC, from 18% to 7%
in SDS and from 20% to 8% in DPC/SDS.
3.4.2. NMR analysis
[Pro3, DLeu9]TL was also investigated by NMR spectroscopy. Due
to the very similar behavior of this peptide in the presence of SDS
and DPC/SDS micelles, as manifested by CD analysis (Fig. 1d and
Table 6), NMR spectroscopy was performed only in SDS and DPC mi-
cellar solutions. Complete 1H NMR chemical shift assignments were
effectively achieved for the peptide according to the Wüthrich proce-
dure [61] (Supplementary Tables S2–S3).
3.4.2.1. [Pro3, DLeu9]TL in SDS solution. Diagnostic NMR parameters ob-
served for [Pro3, DLeu9]TL in SDS solution indicated some conformational
propensity toward helical or turn structures. Hα atoms from residue 2 toTable 4
Peptides' activity on clinical isolates of C. albicans.
Microorganisms MICa (μM)
TL [Pro3, DLeu9]TL
Candida albicans strain n. 1 6 6
Candida albicans strain n. 2 3 3
Candida albicans strain n. 3 6 6
Candida albicans strain n. 4b 3 3
a The reported MIC values are those obtained from at least three readings out of four
independent measurements.
b Resistance phenotype: ﬂuconazol, amphotericin B.residue 13 experienced an upﬁeld shift of the NMR signals compared to
those found for the same amino acids in the random coil state [62,63]
(Supplementary Fig. S1). Only amide protons of residues Phe5, Lys7,
and Ile12 showed exchange rates and temperature coefﬁcients indicating
that they were shielded from the solvent (Supplementary Table S2). The
presence of a number of dαN(i,i+2) NOE contacts indicated the pres-
ence of helical and turn structures along the peptide, in line with CD re-
sults. Structure calculation gave an ensemble of 20 structures satisfying
the NMR-derived constraints (structural statistics are reported in
Table 7). Many structures (17 of 20) of [Pro3, DLeu9]TL showed a
β-turn centered on Pro3 and Trp4 followed by an α-helix along residues
5–8 (Fig. 2a). Also, a β-turn centered on Arg11 and Ile12 could be ob-
served in several structures (15 of 20).
3.4.2.2. [Pro3, DLeu9]TL in DPC solution. [Pro3, DLeu9]TL in DPC solution
exhibited NMR spectral features (Supplementary Fig. S1 and Table
S3) resembling those of the parent [Pro3]TL in the same solution
[44]. Upﬁeld shift of the Hα NMR signals, low values of the exchange
rates and temperature coefﬁcients of the amide protons, and diagnos-
tic NOEs (Supplementary Table S3) indicated that central residues are
in a helical conformation. Structure calculation gave an ensemble of
20 structures satisfying the NMR-derived constraints (violations
smaller than 0.50 Å). As found for [Pro3]TL, a β-turn centered on
Pro3 and Trp4 was detected in the structure of [Pro3, DLeu9]TL in
DPC micelles. It was followed by a 3–10 helix along residues 5–7,
and a bulged helical structure along residues 5–10 (18 of 20 struc-
tures). The bulged helix was stabilized by a H-bond between the NH
group of Gly10 and the C_O group of Phe5 (Fig. 2b). An α-helical con-
formation along residues 10–13 was noted in 5 of 20 structures.
3.5. Permeabilization of large unilamellar vesicles (LUV) by the peptides
To know whether the highly reduced hemolytic activity of [Pro3,
DLeu9]TL was due to its inability to permeate the erythrocyte mem-
brane, we used calcein LUV made of POPC/Cho (9:1,w:w) which
mimic the lipid composition of the outer leaﬂet of mammalian eryth-
rocyte membrane. In addition, liposomes made of POPE/POPG (7:3,
w:w) were also included to mimic the lipid composition of thePeptides' cytotoxicity on HaCat cells.
Peptide concentration (μM) Cell viabilitya
(%)
TL [Pro3, DLeu9]TL
48 23 85
24 26 100
12 29 100
6 39 100
3 77 100
a Cell viability is expressed as percentage with respect to the control (cells not treat-
ed with the peptide). Values are the mean of three independent experiments with SD
not exceeding 2%.
Fig. 1. CD spectra of [Pro3]TL and its analogues in a) DPC, b) SDS, c) DPC/SDS. ([Pro3]TL, blue line; [Pro3, DLys7]TL, heavenly line; [Pro3, DPhe8]TL, violet line; [Pro3, DLeu9]TL, black
line; [Pro3, DArg11]TL, green line; [Pro3, DIle12]TL, yellow line; [Pro3, DLeu13]TL, red line). d) CD spectra of [Pro3, DLeu9]TL in DPC (dotted line), SDS (dashed line), and DPC/SDS (solid
line).
Table 7
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(e.g. E. coli). The membrane of a representative Gram-positive bacte-
rium (e.g. S. aureus) was, instead, mimicked by POPG/CL (6:4, w/w)
LUV.
Different concentrations of the peptide were added to the LUV
suspension and membrane permeability was measured by following
ﬂuorescence recovery due to calcein release from the vesicles
(Fig. 3). Interestingly, the effect induced by [Pro3, DLeu9]TL (empty
symbols) on the permeation of both POPE/POPG (blue triangles)
and POPG/CL (red squares) LUV was similar to that of TL (ﬁlled sym-
bols) at a peptide/lipid molar ratio of 0.002 and 0.004. Differently, at
the highest peptide/lipid molar ratio used (0.08), the extent of calcein
release caused by TL was about 2-fold higher than that of [Pro3,
DLeu9]TL. The overall low calcein leakage from these lipid vesicles
could be related to a different peptide's conformation/oligomeric
state with respect to that adopted upon contact with bacterial cell
wall components which are absent in model membranes. Further-
more, the preference of both TL and [Pro3, DLeu9]TL for Gram-
positive over Gram-negative model membrane systems correlated
with the higher antimicrobial activity of these peptides towards
Gram-positive bacterial strains compared to Gram-negatives (see
the corresponding MIC values in Table 2).Table 6
α-Helix percentage of TL-analogues.
Peptides [Pro3]
TL
[Pro3,
DLys7]
TL
[Pro3,
DPhe8]
TL
[Pro3,
DLeu9]
TL
[Pro3,
DArg11]
TL
[Pro3,
DIle12]
TL
[Pro3,
DLeu13]
TL
DPC 25a 10 24 15 18 20 22
SDS 22a 7 14 10 12 15 18
DPC–SDS 23 8 14 11 12 17 20
a See reference [44].In contrast, when the zwitterionic POPC/Cho LUV (black circles)
were employed, the effect of [Pro3, DLeu9]TL was drastically less pro-
nounced (3 to 8-fold lower) than that of TL at all concentrations used,
suggesting that the loss in hemolytic activity of [Pro3, DLeu9]TL ismainly
related to its incapability to damage the erythrocyte membrane.
4. Discussion
Therapeutic peptide antibiotics should have advantages over
conventional drugs, due to their diverse potential applications, rang-
ing from antimicrobial to immunomodulatory and/or endotoxin-
neutralizing activities. They can be used either alone or in combination
to synergize one with each other [64]. Although the efﬁcacy of these
AMPs is in general less than certain traditional antibiotics, one of their
attractive properties is the ability to kill sensitive and multi-drug resis-
tant strains at similar concentrations [32]. Moreover, compared to clas-
sical antibiotics, AMPs act extremely rapidly and can attack multiple
bacterial cellular targets [22]. Among AMPs from frog skin, temporins
represent promising potential molecules to be developed for clinics.Structural statistics for the ﬁnal 20 structures of [Pro , DLeu ]TL in SDS and in DPC
micelles.
Parameter [Pro3, DLeu9]TL
in SDS
[Pro3, DLeu9]TL
in DPC
NOE distance restraints
Total 109 135
Intra 51 55
Short 48 57
Medium 10 23
Backbone RMSD (Å) 0.79 0.48
Overall RMSD (Å) 1.45 0.99
Max restraint violation (Å) 0.68 0.50
Fig. 2. Superposition of the 10 lowest energy conformers of [Pro3, DLeu9]TL in SDS (a), and DPC (b). Structures were superimposed using the backbone heavy atoms. Heavy atoms
are shown with different colors (carbon, green; nitrogen, blue; oxygen, red). Hydrogen atoms are not shown for clarity. Only side chains of the lowest energy conformer are
displayed for clarity. Backbone atoms of the lowest energy conformer were evidenced as a ribbon.
658 P. Grieco et al. / Biochimica et Biophysica Acta 1828 (2013) 652–660Previously, we studied the effect of the replacement of cationic and hy-
drophobic residues of the native TL on its antimicrobial and hemolytic
activities. Furthermore, the effects of such substitutions on the helicity,
hydrophobicity and hydrophobic moment of the peptide were ana-
lyzed. We demonstrated that the nature of cationic residues can
differently modify the antimicrobial/hemolytic activity of TL, without
changing its helical content. In contrast, a direct correlation was re-
vealed between the percentage of peptide's helicity in zwitterionic mi-
celles and its toxicity on human red blood cells. In addition,we observed
that replacement of Gly10 with a leucine residue almost abrogated the
antimicrobial efﬁcacy of TL causing a dramatic enhancement of hemoly-
sis, probably due to oligomerization of the peptide.
Here, we performed SAR studies using six different analogues of TL,
each containing a single D amino acid starting from position 7 (Table 1).
Biological data have proved that interruption of the helical content of
[Pro3]TL by replacement of D versus L amino acids diminishes the
peptide's antibacterial activity (Table 3). Interestingly, anti-yeast activ-
ity is slightly decreased for all D analogues, but it is preserved for [Pro3,
DLeu9]TL (Table 2). Hemolytic activity drops below8% at 6 μMfor all an-
alogues but [Pro3, DPhe8]TL (Table 3). However, the most promising
outcome is that the anti-Candida activity of [Pro3, DLeu9]TL analogue is
preserved also against an antimycotic resistant strain (Table 4), while
the peptide is practically non-toxic towards human erythrocytes and
keratinocytes (Tables 3 and 5). Considering the conformational behav-
ior, the incorporation of D amino acids reduces the α-helical structure
of [Pro3]TL to different degrees, depending on their position and com-
position of the lipid environment (Table 6). These substitutions can20
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Fig. 3. Calcein leakage from POPE/POPG (blue triangles), POPG/CL (red squares) and
POPC/Cho (black circles) LUV after addition of TL (ﬁlled symbols) or [Pro3, DLeu9]TL
(empty symbols) at different concentrations. Fluorescence recovery was measured
for 10 min after the peptides were mixed with the vesicles, and its maxima were
reported. Leakage was calculated as indicated in the Materials and methods. Values
are means of three independent measurements with ±SD.also differently inﬂuence the peptide's biological activity (Table 2). Re-
duction of the helicity is higher when the central Lys7 residue is re-
placed by DLys compared to the effects caused by D substitution at
other positions. In the case of [Pro3, DLeu9]TL, NMR analysis indicated
that the helical structure inDPCmicelles is partially conserved by anun-
usual i to i+5 hydrogen bond between Phe5 and Gly10 residues
(Fig. 2b). The parent peptides TL and [Pro3]TL showed a classical
α-helical structure along these residues [44]. Changing of the backbone
conformation also affects the distribution of the side chains of the pep-
tide. As themain difference, Phe8 and DLeu9 side chains are closer to the
polar side of the helix (deﬁned by the side chains of Lys7 and Arg11) in
[Pro3, DLeu9]TL compared to TL and [Pro3]TL (Supplementary Fig. S2),
thus decreasing the amphipathicity of the ﬁrst peptide. Note that deter-
gent micelles represent a reliable membrane mimetic model and have
been used extensively for solution NMR spectroscopy of AMPs and
membrane proteins [19]. However, to verify whether the peptide's con-
formation is preserved in more complex lipid environments that better
mimic a biological membrane, solid-state NMR studies in phospholipid
bilayers will be next performed.
In agreement with our previous results [40], the hemolytic activity
of the D amino acid containing analogues correlates well with their in-
creased helical content in DPC (see Tables 3 and 6). Thus, [Pro3, DLys7]
TL and [Pro3, DLeu9]TL are the less toxic peptides; [Pro3, DPhe8]TL,
with the highest percentage of α-helix, the most hemolytic one. Fur-
thermore, in line with our recent ﬁndings [40], breaking of the helical
structure at the C-terminal half reduces the antibacterial activity of
[Pro3]TL. In contrast, the anti-yeast efﬁcacy is not directly dependent
on the helicity of the peptide. Indeed, among the six analogues, [Pro3,
DLeu9]TL is endowed with the highest anti-yeast activity, despite hav-
ing a very low content of helix in DPC/SDS micelle solutions (11% vs
23% of [Pro3]TL). Therefore, we can conclude that interruption of
the α-helix of [Pro3]TL at position 9 does not compromise anti-
Candida and anti-Saccharomyces activities of this peptide and practi-
cally abolishes its toxicity towards mammalian cells. This is presum-
ably due to its inability to disrupt the membrane of these cells, as
revealed by the LUV leakage experiments (Fig. 3).
Although usually harbored as a harmless commensal microbe of
healthy humans, C. albicans can cause a variety of superﬁcial and
deep-seated mycoses, particularly in immunocompromised and neu-
tropenic hosts [65]. Such Candida can either circulate in the blood
(e.g. the erythrocytes) or be located at many infection sites (e.g. the
skin, the oral, ocular and genital epithelia). In these cases, candidosis
is becoming a life-threatening disease in patients undergoing aggres-
sive chemotherapy or having T-cell leukemia virus-associated immu-
nodeﬁciencies. Relatively few antifungal agents are available, particularly
for deep-seated Candida mycoses. Amphotericin B and the azole drugs
such as itraconazole and ketoconazole are currently used. More recently,
ﬂuconazole has been employed, but its use is quite restricted due to the
659P. Grieco et al. / Biochimica et Biophysica Acta 1828 (2013) 652–660limited spectrum of activity and to the emerging appearance of Candida
strains resistant to it. Therefore, the discovery of new compounds to
treat Candida-associated infections, without being toxic to mammalian
cells, is urgently needed.
5. Conclusion
Importantly, the results of the present study have lead to the iden-
tiﬁcation of a TL analogue ([Pro3, DLeu9]TL) practically devoid of cyto-
lytic effects in vitro and which preserves the effectiveness of the
native peptide against C. albicans. Overall, our studies have shown
that substitution of Gln3 with a proline residue and replacement of
Leu9 with its D enantiomer play a key role in breaking the helicity of
TL as well as in distinguishing between eukaryotic and prokaryotic
membranes. Indeed, while such changes retain the peptide's antimi-
crobial activity, presumably by preserving its ability to lead to micro-
bial membrane injury, they cause a drastic reduction in peptide's
ability to damage mammalian cell membranes, thus abolishing the
toxic effects of the peptide on human cells such as erythrocytes and
keratinocytes. In addition, incorporation of a D amino acid within
the peptide sequence should increase its biostability to proteolytic
enzymes, a fundamental requirement for potential use in clinics.
Overall, these ﬁndings should assist in the future development of se-
lective and economically feasible anti-Candida agents, starting from
the short-sized TL template.
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